Further research indicated that the Srx-TXNDC5 complex may be used to predict the survival probability for lung cancer patients and as a therapeutic target or molecular diagnostic tool in human lung cancer pathogenesis (147). This evidence concerns the gene SRXN1 and lung cancer.